Erschienen in:
01.10.2009 | Melanomas
Prognostic False-Positivity and Cost-Effectiveness in Sentinel Node Biopsy in Melanoma
verfasst von:
J. Meirion Thomas
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 10/2009
Einloggen, um Zugang zu erhalten
Excerpt
The calculations made by Morton et al.
1 about the cost-effectiveness of sentinel node biopsy (SNB), published in a recent issue of this
Journal, depend entirely on the accuracy of the claimed 20% survival difference between two groups of patients having immediate (122/764) versus delayed lymphadenectomy (78/500) as reported in the third interim analysis of MSLT-1
2 (72.3 ± 4.6% versus 52.4 ± 5.9%). …